By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews today reported that it has cut its first-quarter net loss 30 percent, even though it had hardly any revenue for the period.

The Toronto-based molecular diagnostics firm brought in total revenues of just C$4,417 (US$4,298) for the three-month period ended March 31, compared to C$259,210 for the first quarter of 2009. The bulk of last year's revenues came from non-refundable license revenue, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.